https://doi.org/10.1021/acs.jmedchem.9b00719
B
Bin Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
295
Papers
4.9K
Citations
37
h-index
103
i10-index
Bin Wang is an academic researcher from Nanjing Brain Hospital. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & Cancer Cells and Metastasis. The author has an h-index of 37, co-authored 251 publications.
ORCID: 0000-0002-2662-1986Papers by this author
works3-[(1<i>S</i>,2<i>S</i>,3<i>R</i>)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
2019 · Journal of Medicinal Chemistry · 202 citations
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma
2015 · Nature Communications · 124 citations
https://doi.org/10.1038/ncomms9699
Robotic versus laparoscopic right colectomy: a meta-analysis
2014 · World Journal of Surgical Oncology · 84 citations
https://doi.org/10.1186/1477-7819-12-274
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
2017 · Cell Death and Disease · 57 citations
https://doi.org/10.1038/cddis.2017.9
Incidence of biliary atresia associated congenital malformations: A retrospective multicenter study in China
2016 · Asian Journal of Surgery · 53 citations
https://doi.org/10.1016/j.asjsur.2016.04.003
The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression
2019 · Cell Death and Disease · 41 citations
https://doi.org/10.1038/s41419-019-1669-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat